Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes

Neuroscience and Biobehavioral Reviews

Volumn 55, Issue , 2015, Pages 119-146

  Higuera Matas, Alejandro ^a   Ucha, Marcos ^a   Ambrosio, Emilio ^a  

^a UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

Adolescence; Cannabinoid; Cognition; Dopamine; Drug addiction; Emotion; Glutamate; Prenatal development

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOL DERIVATIVE; CANNABIS; ENDOCANNABINOID; GLUTAMIC ACID; OPIATE RECEPTOR; CANNABINOID;

BINDING AFFINITY; BRAIN METABOLISM; CANNABIS USE; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG TRAFFIC; EMOTIONALITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GABAERGIC SYSTEM; HUMAN; LEARNING; MATERNAL SMOKING; MEMORY; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM FUNCTION; NEUROCHEMISTRY; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NONHUMAN; PERINATAL DEVELOPMENT; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGICAL ASPECT; REVIEW; SEX DIFFERENCE; ADOLESCENT; CHEMICALLY INDUCED; DEVELOPMENTAL DISABILITIES; DRUG EFFECTS; FEMALE; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PSYCHOLOGY;

ADOLESCENT; CANNABINOIDS; CENTRAL NERVOUS SYSTEM; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; FEMALE; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84929314776     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2015.04.020     Document Type: Review

References (237)

1. Abboussi O., Tazi A., Paizanis E., El Ganouni S. Chronic exposure to WIN55,212-2 affects more potently spatial learning and memory in adolescents than in adult rats via a negative action on dorsal hippocampal neurogenesis. Pharmacol. Biochem. Behav. 2014, 120:95-102. 10.1016/j.pbb.2014.02.014.
2. Abush H., Akirav I. Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory. Neuropsychopharmacology 2013, 38:1521-1534. 10.1038/npp.2013.51.
3. Abush H., Akirav I. Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats. PLOS ONE 2012, 7:e31731. 10.1371/journal.pone.0031731.
4. Aguado T., Monory K., Palazuelos J., Stella N., Cravatt B., Lutz B., Marsicano G., Kokaia Z., Guzman M., Galve-Roperh I. The endocannabinoid system drives neural progenitor proliferation. FASEB J. 2005, 19:1704-1706. 10.1096/fj.05-3995fje.
5. Alpár A., Tortoriello G., Calvigioni D., Niphakis M.J., Milenkovic I., Bakker J., Cameron G.A., Hanics J., Morris C.V., Fuzik J., Kovacs G.G., Cravatt B.F., Parnavelas J.G., Andrews W.D., Hurd Y.L., Keimpema E., Harkany T. Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. Nat. Commun. 2014, 5:4421. 10.1038/ncomms5421.
6. Antonelli T., Tomasini M.C., Tattoli M., Cassano T., Tanganelli S., Finetti S., Mazzoni E., Trabace L., Steardo L., Cuomo V., Ferraro L. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb. Cortex 2005, 15:2013-2020. 10.1093/cercor/bhi076.
7. Badiani A., Boden J.M., De Pirro S., Fergusson D.M., Horwood L.J., Harold G.T. Tobacco smoking and cannabis use in a longitudinal birth cohort: evidence of reciprocal causal relationships. Drug Alcohol Depend. 2015, 10.1016/j.drugalcdep.2015.02.015.
8. Bambico F.R., Nguyen N.T., Katz N., Gobbi G. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol. Dis. 2010, 37:641-655. S0969-9961(09)00342-8 [pii]. 10.1016/j.nbd.2009.11.020.
9. Basavarajappa B.S., Nagre N.N., Xie S., Subbanna S. Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. Hippocampus 2014, 24:808-818. 10.1002/hipo.22272.
10. Batalla A., Bhattacharyya S., Yucel M., Fusar-Poli P., Crippa J.A., Nogue S., Torrens M., Pujol J., Farre M., Martin-Santos R. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLOS ONE 2013, 8:e55821. 10.1371/journal.pone.0055821.
11. Battistella G., Fornari E., Annoni J.-M., Chtioui H., Dao K., Fabritius M., Favrat B., Mall J.-F., Maeder P., Giroud C. Long-term effects of cannabis on brain structure. Neuropsychopharmacology 2014, 39:2041-2048. 10.1038/npp.2014.67.
12. Behan A.T., Hryniewiecka M., O'Tuathaigh C.M., Kinsella A., Cannon M., Karayiorgou M., Gogos J.A., Waddington J.L., Cotter D.R. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology 2012, 37:1773-1783. 10.1038/npp.2012.24.
13. Belue R.C., Howlett A.C., Westlake T.M., Hutchings D.E. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 1995, 17:25-30.
14. Benagiano V., Lorusso L., Flace P., Girolamo F., Rizzi A., Sabatini R., Auteri P., Bosco L., Cagiano R., Ambrosi G. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex. Neuroscience 2007, 149:592-601. 10.1016/j.neuroscience.2007.07.050.
15. Benes F.M. Myelination of cortical-hippocampal relays during late adolescence. Schizophr. Bull. 1989, 15:585-593.
16. Berghuis P., Dobszay M.B., Wang X., Spano S., Ledda F., Sousa K.M., Schulte G., Ernfors P., Mackie K., Paratcha G., Hurd Y.L., Harkany T. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19115-19120. 10.1073/pnas.0509494102.
17. Berghuis P., Rajnicek A.M., Morozov Y.M., Ross R.A., Mulder J., Urban G.M., Monory K., Marsicano G., Matteoli M., Canty A., Irving A.J., Katona I., Yanagawa Y., Rakic P., Lutz B., Mackie K., Harkany T. Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 2007, 316:1212-1216. 10.1126/science.1137406.
18. Berrendero F., García-Gil L., Hernández M.L., Romero J., Cebeira M., de Miguel R., Ramos J.A., Fernández-Ruiz J.J. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development. Development 1998, 125:3179-3188.
19. Berrendero F., Sepe N., Ramos J.A., Di Marzo V., Fernandez-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999, 33:181-191. 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R.
20. Biscaia M., Fernández B., Higuera-Matas A., Miguéns M., Viveros M.-P.P., García-Lecumberri C., Ambrosio E., Fernandez B., Miguens M., Garcia-Lecumberri C. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system. Neuropharmacology 2008, 54:863-873. S0028-3908(08)00020-8 [pii]. 10.1016/j.neuropharm.2008.01.006.
21. Biscaia M., Marin S., Fernandez B., Marco E.M., Rubio M., Guaza C., Ambrosio E., Viveros M.P. Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology (Berl). 2003, 170:301-308. 10.1007/s00213-003-1550-7.
22. Blakemore S.J. Teenage kicks: cannabis and the adolescent brain. Lancet 2013, 381:888-889. S0140-6736(12)61578-5 [pii]. 10.1016/S0140-6736(12)61578-5.
23. Blakemore S.-J.J. Imaging brain development: the adolescent brain. Neuroimage 2012, 61:397-406. S1053-8119(11)01362-0 [pii]. 10.1016/j.neuroimage.2011.11.080.
24. Bonnin A., de Miguel R., Rodriguez-Manzaneque J.C., Fernandez-Ruiz J.J., Santos A., Ramos J.A. Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids. Brain Res. Dev. Brain Res. 1994, 81:147-150.
25. Bortolato M., Bini V., Frau R., Devoto P., Pardu A., Fan Y., Solbrig M.V. Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats. Eur. Neuropsychopharmacol. 2014, 24:974-985. 10.1016/j.euroneuro.2013.12.011.
26. Bortolato M., Frau R., Orrù M., Casti A., Aru G.N., Fà M., Manunta M., Usai A., Mereu G., Gessa G.L. Prenatal exposure to a cannabinoid receptor agonist does not affect sensorimotor gating in rats. Eur. J. Pharmacol. 2006, 531:166-170. 10.1016/j.ejphar.2005.12.017.
27. Brown H.L., Graves C.R. Smoking and marijuana use in pregnancy. Clin. Obstet. Gynecol. 2013, 56:107-113. 10.1097/GRF.0b013e318282377d.
28. Burns L., Mattick R.P., Cooke M. The use of record linkage to examine illicit drug use in pregnancy. Addiction 2006, 101:873-882. 10.1111/j.1360-0443.2006.01444.x.
29. Byrnes J.J., Johnson N.L., Schenk M.E., Byrnes E.M. Cannabinoid exposure in adolescent female rats induces transgenerational effects on morphine conditioned place preference in male offspring. J. Psychopharmacol. 2012, 26:1348-1354. 10.1177/0269881112443745.
30. Cadoni C., Simola N., Espa E., Fenu S., Di Chiara G. Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats. Addict. Biol. 2013, 10.1111/adb.12085.
31. Calvigioni D., Hurd Y.L., Harkany T., Keimpema E. Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur. Child Adolesc. Psychiatry 2014, 10.1007/s00787-014-0550-y.
32. Campolongo P., Trezza V., Cassano T., Gaetani S., Morgese M.G., Ubaldi M., Soverchia L., Antonelli T., Ferraro L., Massi M., Ciccocioppo R., Cuomo V. Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats. Addict. Biol. 2007, 12:485-495. 10.1111/j.1369-1600.2007.00074.x.
33. Campolongo P., Trezza V., Ratano P., Palmery M., Cuomo V. Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents. Psychopharmacology (Berl). 2011, 214:5-15. 10.1007/s00213-010-1892-x.
34. Carli M., Invernizzi R.W. Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task. Front. Neural Circ. 2014, 8:58. 10.3389/fncir.2014.00058.
35. Cass D.K., Flores-Barrera E., Thomases D.R., Vital W.F., Caballero A., Tseng K.Y. CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex. Mol. Psychiatry 2014, 19:536-543. 10.1038/mp.2014.14.
36. Castaldo P., Magi S., Cataldi M., Arcangeli S., Lariccia V., Nasti A.A., Ferraro L., Tomasini M.C., Antonelli T., Cassano T., Cuomo V., Amoroso S. Altered regulation of glutamate release and decreased functional activity and expression of GLT1 and GLAST glutamate transporters in the hippocampus of adolescent rats perinatally exposed to Delta(9)-THC. Pharmacol. Res. 2010, 61:334-341. S1043-6618(09)00277-1 [pii]. 10.1016/j.phrs.2009.11.008.
37. Castaldo P., Magi S., Gaetani S., Cassano T., Ferraro L., Antonelli T., Amoroso S., Cuomo V. Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex. Neuropharmacology 2007, 53:369-378. S0028-3908(07)00155-4 [pii]. 10.1016/j.neuropharm.2007.05.019.
38. Castelli M.P., Paola Piras A., D'Agostino A., Pibiri F., Perra S., Gessa G.L., Maccarrone M., Pistis M. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. Eur. J. Pharmacol. 2007, 573:11-19. S0014-2999(07)00763-7 [pii]. 10.1016/j.ejphar.2007.06.047.
39. Cha Y.M., Jones K.H., Kuhn C.M., Wilson W.A., Swartzwelder H.S. Sex differences in the effects of delta9-tetrahydrocannabinol on spatial learning in adolescent and adult rats. Behav. Pharmacol. 2007, 18:563-569.
40. Cha Y.M., White A.M., Kuhn C.M., Wilson W.a, Swartzwelder H.S. Differential effects of delta9-THC on learning in adolescent and adult rats. Pharmacol. Biochem. Behav. 2006, 83:448-455. S0091-3057(06)00065-7 [pii]. 10.1016/j.pbb.2006.03.006.
41. Chadwick B., Miller M.L., Hurd Y.L. Cannabis use during adolescent development: susceptibility to psychiatric illness. Front. Psychiatry 2013, 4:129. 10.3389/fpsyt.2013.00129.
42. Chadwick B., Saylor A.J., Lopez H.H. Adolescent cannabinoid exposure attenuates adult female sexual motivation but does not alter adulthood CB1R expression or estrous cyclicity. Pharmacol. Biochem. Behav. 2011, 100:157-164. S0091-3057(11)00242-5 [pii]. 10.1016/j.pbb.2011.07.006.
43. Chapman S.L., Wu L.T. Substance use among adolescent mothers: a review. Child Youth Serv. Rev. 2013, 35:806-815. 10.1016/j.childyouth.2013.02.004.
44. Cornelius M.D., Leech S.L., Goldschmidt L. Characteristics of persistent smoking among pregnant teenagers followed to young adulthood. Nicotine Tob. Res. 2004, 6:159-169. 10.1080/14622200310001656975.
45. Dalterio S., Blum K., DeLallo L., Sweeney C., Briggs A., Bartke A. Perinatal exposure to delta 9-THC in mice: altered enkephalin and norepinephrine sensitivity in vas deferens. Subst. Alcohol Actions. Misuse 1980, 1:467-471.
46. Dalterio S., Steger R., Mayfield D., Bartke A. Early cannabinoid exposure influences neuroendocrine and reproductive functions in male mice: I. Prenatal exposure. Pharmacol. Biochem. Behav. 1984, 20:107-113.
47. Dalterio S., Steger R., Mayfield D., Bartke A. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects. Pharmacol. Biochem. Behav. 1984, 20:115-123.
48. Day N.L., Cottreau C.M., Richardson G.A. The epidemiology of alcohol, marijuana, and cocaine use among women of childbearing age and pregnant women. Clin. Obstet. Gynecol. 1993, 36:232-245.
49. Day N.L., Goldschmidt L., Thomas C.A. Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14. Addiction 2006, 101:1313-1322. 10.1111/j.1360-0443.2006.01523.x.
50. Day N.L., Leech S.L., Goldschmidt L. The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicol. Teratol. 2011, 33:129-136. S0892-0362(10)00157-1 [pii]. 10.1016/j.ntt.2010.07.006.
51. Day N.L., Richardson G.A., Geva D., Robles N. Alcohol, marijuana, and tobacco: effects of prenatal exposure on offspring growth and morphology at age six. Alcohol. Clin. Exp. Res. 1994, 18:786-794.
52. Delegación del Gobierno para el Plan Nacional sobre Drogas Encuesta estatal sobre uso de drogas en enseñanzas secundarias (ESTUDES) 2012/2013 2013.
53. Derauf C., Kekatpure M., Neyzi N., Lester B., Kosofsky B. Neuroimaging of children following prenatal drug exposure. Semin. Cell Dev. Biol. 2009, 20:441-454. S1084-9521(09)00039-1 [pii]. 10.1016/j.semcdb.2009.03.001.
54. Díaz-Alonso J., Aguado T., de Salas-Quiroga A., Ortega Z., Guzmán M., Galve-Roperh I. CB1 cannabinoid receptor-dependent activation of mTORC1/Pax6 signaling drives Tbr2 expression and basal progenitor expansion in the developing mouse cortex. Cereb. Cortex 2014, 10.1093/cercor/bhu039.
55. DiNieri J.A., Wang X., Szutorisz H., Spano S.M., Kaur J., Casaccia P., Dow-Edwards D., Hurd Y.L. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol. Psychiatry 2011, 70:763-769. S0006-3223(11)00672-X [pii]. 10.1016/j.biopsych.2011.06.027.
56. Duff G., Argaw A., Cecyre B., Cherif H., Tea N., Zabouri N., Casanova C., Ptito M., Bouchard J.-F. Cannabinoid receptor CB2 modulates axon guidance. PLOS ONE 2013, 8:e70849. 10.1371/journal.pone.0070849.
57. Economidou D., Mattioli L., Ubaldi M., Lourdusamy A., Soverchia L., Hardiman G., Campolongo P., Cuomo V., Ciccocioppo R. Role of cannabinoidergic mechanisms in ethanol self-administration and ethanol seeking in rat adult offspring following perinatal exposure to Delta9-tetrahydrocannabinol. Toxicol. Appl. Pharmacol. 2007, 223:73-85. S0041-008X(07)00238-4 [pii]. 10.1016/j.taap.2007.05.008.
58. Ehrenreich H., Rinn T., Kunert H.J., Moeller M.R., Poser W., Schilling L., Gigerenzer G., Hoehe M.R. Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl). 1999, (142):295-301.
59. El Marroun H., Hudziak J.J., Tiemeier H., Creemers H., Steegers E.A., Jaddoe V.W., Hofman A., Verhulst F.C., van den Brink W., Huizink A.C. Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend. 2011, (118):470-474. S0376-8716(11)00130-X [pii]. 10.1016/j.drugalcdep.2011.03.004.
60. El Marroun H., Jaddoe V.W., Hudziak J.J., Roza S.J., Steegers E.A., Hofman A., Verhulst F.C., White T.J., Stricker B.H., Tiemeier H. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch. Gen. Psychiatry 2012, 69:706-714. 10.1001/archgenpsychiatry.2011.2333.
61. El Marroun H., Tiemeier H., Jaddoe V.W., Hofman A., Mackenbach J.P., Steegers E.A., Verhulst F.C., van den Brink W., Huizink A.C. Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study. Drug Alcohol Depend. 2008, 98:218-226. S0376-8716(08)00201-9 [pii]. 10.1016/j.drugalcdep.2008.05.010.
62. El Marroun H., Tiemeier H., Jaddoe V.W., Hofman A., Verhulst F.C., van den Brink W., Huizink A.C. Agreement between maternal cannabis use during pregnancy according to self-report and urinalysis in a population-based cohort: the Generation R Study. Eur. Addict. Res. 2011, 17:37-43. 10.1159/000320550.
63. El Marroun H., Tiemeier H., Steegers E.A., Jaddoe V.W., Hofman A., Verhulst F.C., van den Brink W., Huizink A.C. Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J. Am. Acad. Child Adolesc. Psychiatry 2009, 48:1173-1181. S0890-8567(09)66073-1 [pii]. 10.1097/CHI.0b013e3181bfa8ee.
64. El Marroun H., Tiemeier H., Steegers E.A., Roos-Hesselink J.W., Jaddoe V.W., Hofman A., Verhulst F.C., van den Brink W., Huizink A.C. A prospective study on intrauterine cannabis exposure and fetal blood flow. Early Hum. Dev. 2010, 86:231-236. S0378-3782(10)00079-4 [pii]. 10.1016/j.earlhumdev.2010.03.006.
65. Ellgren M., Artmann A., Tkalych O., Gupta A., Hansen H.S., Hansen S.H., Devi L.A., Hurd Y.L. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur. Neuropsychopharmacol. 2008, 18:826-834. S0924-977X(08)00170-3 [pii]. 10.1016/j.euroneuro.2008.06.009.
66. Ellgren M., Hurd Y.L., Franck J. Amphetamine effects on dopamine levels and behavior following cannabinoid exposure during adolescence. Eur. J. Pharmacol. 2004, 497:205-213. S0014-2999(04)00689-2 [pii]. 10.1016/j.ejphar.2004.06.048.
67. Ellgren M., Spano S.M., Hurd Y.L. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology 2007, 32:607-615. 10.1038/sj.npp.1301127.
68. European Monitoring Centre for Drugs and Drug Addiction European Drug Report 2014: Trends and Developments 2014.
69. Fergusson D.M., Horwood L.J., Northstone K. Maternal use of cannabis and pregnancy outcome. BJOG 2002, 109:21-27.
70. Fontes M.A., Bolla K.I., Cunha P.J., Almeida P.P., Jungerman F., Laranjeira R.R., Bressan R.A., Lacerda A.L. Cannabis use before age 15 and subsequent executive functioning. Br. J. Psychiatry 2011, 198:442-447. 10.1192/bjp.bp.110.077479.
71. Fried P., Watkinson B., James D., Gray R. Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ 2002, 166:887-891.
72. Friguls B., Joya X., Garcia-Serra J., Gomez-Culebras M., Pichini S., Martinez S., Vall O., Garcia-Algar O. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island. Addiction 2012, 107:1471-1479. 10.1111/j.1360-0443.2012.03828.x.
73. Gaalema D.E., Higgins S.T., Pepin C.S., Heil S.H., Bernstein I.M. Illicit drug use among pregnant women enrolled in treatment for cigarette smoking cessation. Nicotine Tob. Res. 2013, 15:987-991. 10.1093/ntr/nts220.
74. Ganon-Elazar E., Akirav I. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J. Neurosci. 2009, 29:11078-11088. 10.1523/JNEUROSCI.1223-09.2009.
75. Garcia L., de Miguel R., Ramos J.A., Fernandez-Ruiz J.J. Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug Alcohol Depend. 1996, 42:155-166.
76. Garcia-Gil L., de Miguel R., Romero J., Perez A., Ramos J.A., Fernandez-Ruiz J.J. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats. Neurotoxicol. Teratol. 1999, 21:277-283. S0892036298000580 [pii].
77. García-Gil L., Romero J., Ramos J.A., Fernández-Ruiz J.J. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to δ9-tetrahydrocannabinol. Drug Alcohol Depend. 1999, 55:127-136. 10.1016/S0376-8716(98)00189-6.
78. Giedd J.N. The teen brain: insights from neuroimaging. J. Adolesc. Health 2008, 42:335-343. 10.1016/j.jadohealth.2008.01.007.
79. Glass M., Dragunow M., Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318. S0306452296004289 [pii].
80. Gleason K.A., Birnbaum S.G., Shukla A., Ghose S. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl. Psychiatry 2012, 2:e199. 10.1038/tp.2012.122.
81. Gomes F.V., Guimarães F.S., Grace A.A. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia. Int. J. Neuropsychopharmacol. 2014, 18. 10.1093/ijnp/pyu018.
82. Gonzalez B., de Miguel R., Martin S., Perez-Rosado A., Romero J., Garcia-Lecumberri C., Fernandez-Ruiz J., Ramos J.A., Ambrosio E. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior. Pharmacol. Biochem. Behav. 2003, 75:577-584.
83. Gonzalez R., Swanson J.M. Long-term effects of adolescent-onset and persistent use of cannabis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:15970-15971. 10.1073/pnas.1214124109.
84. Gordon J.A., Hen R. The serotonergic system and anxiety. Neuromolecular Med. 2004, 5:27-40. 10.1385/NMM:5:1:027.
85. Grant I., Gonzalez R., Carey C.L., Natarajan L., Wolfson T. Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study. J. Int. Neuropsychol. Soc. 2003, 9:679-689. 10.1017/S1355617703950016.
86. Gruber S.A., Dahlgren M.K., Sagar K.A., Gonenc A., Killgore W.D. Age of onset of marijuana use impacts inhibitory processing. Neurosci. Lett. 2012, 511:89-94. S0304-39401200094-8 [pii]. 10.1016/j.neulet.2012.01.039.
87. Harte L.C., Dow-Edwards D. Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat. Neurotoxicol. Teratol. 2010, 32:515-524. S0892-0362(10)00109-1 [pii]. 10.1016/j.ntt.2010.05.001.
88. Higuera-Matas A., Botreau F., Del Olmo N., Miguens M., Olias O., Montoya G.L., Garcia-Lecumberri C., Ambrosio E. Periadolescent exposure to cannabinoids alters the striatal and hippocampal dopaminergic system in the adult rat brain. Eur. Neuropsychopharmacol. 2010, 20:895-906. S0924-977X(10)00144-6 [pii]. 10.1016/j.euroneuro.2010.06.017.
89. Higuera-Matas A., Botreau F., Miguens M., Del Olmo N., Borcel E., Perez-Alvarez L., Garcia-Lecumberri C., Ambrosio E., Miguéns M., Pérez-Alvarez L., García-Lecumberri C. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory. Pharmacol. Biochem. Behav. 2009, 93:482-490. S0091-3057(09)00209-3 [pii]. 10.1016/j.pbb.2009.06.013.
90. Higuera-Matas A., Miguens M., Coria S.M., Assis M.A., Borcel E., Del Olmo N., Ambrosio E. Sex-specific disturbances of the glutamate/GABA balance in the hippocampus of adult rats subjected to adolescent cannabinoid exposure. Neuropharmacology 2012, 62:1975-1984. S0028-3908(12)00004-4 [pii]. 10.1016/j.neuropharm.2011.12.028.
91. Higuera-Matas A., Soto-Montenegro M.L., del Olmo N., Miguens M., Torres I., Vaquero J.J., Sanchez J., Garcia-Lecumberri C., Desco M., Ambrosio E. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology 2008, 33:806-813.
92. Higuera-Matas A., Soto-Montenegro M.L., Montoya G.L., García-Vázquez V., Pascau J., Miguéns M., Del Olmo N., Vaquero J.J., García-Lecumberri C., Desco M., Ambrosio E. Chronic cannabinoid administration to periadolescent rats modulates the metabolic response to acute cocaine in the adult brain. Mol. Imaging Biol. 2011, 13:411-415. 10.1007/s11307-010-0388-8.
93. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
94. Huizink A.C. Prenatal cannabis exposure and infant outcomes: overview of studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 52:45-52. 10.1016/j.pnpbp.2013.09.014.
95. Hurd Y.L., Michaelides M., Miller M.L., Jutras-Aswad D. Trajectory of adolescent cannabis use on addiction vulnerability. Neuropharmacology 2014, 76(Pt B):416-424. 10.1016/j.neuropharm.2013.07.028.
96. Hurd Y.L., Wang X., Anderson V., Beck O., Minkoff H., Dow-Edwards D. Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol. Teratol. 2005, 27:221-229. S0892-0362(04)00150-3 [pii]. 10.1016/j.ntt.2004.11.002.
97. Huttenlocher P.R., Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 1997, 387:167-178. 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z.
98. Jaques S.C., Kingsbury A., Henshcke P., Chomchai C., Clews S., Falconer J., Abdel-Latif M.E., Feller J.M., Oei J.L. Cannabis, the pregnant woman and her child: weeding out the myths. J. Perinatol. 2014, 34:417-424. 10.1038/jp.2013.180.
99. Jiang S., Fu Y., Williams J., Wood J., Pandarinathan L., Avraham S., Makriyannis A., Avraham S., Avraham H.K. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells. PLoS ONE 2007, 2:e641. 10.1371/journal.pone.0000641.
100. Kameda M., Taylor C.J., Walker T.L., Black D.M., Abraham W.C., Bartlett P.F. Activation of latent precursors in the hippocampus is dependent on long-term potentiation. Transl. Psychiatry 2012, 10.1038/tp.2011.70.
101. Kandel D.B., Yamaguchi K., Klein L.C. Testing the Gateway Hypothesis. Addiction 2006, 101:470-476.
102. Kawash G.F., Yeung D.L., Berg S.D. Effects of administration of cannabis resin during pregnancy on emotionality and learning in rats' offspring. Percept. Mot. Skills 1980, 50:359-365.
103. Keimpema E., Barabas K., Morozov Y.M., Tortoriello G., Torii M., Cameron G., Yanagawa Y., Watanabe M., Mackie K., Harkany T. Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J. Neurosci. 2010, 30:13992-14007. 10.1523/JNEUROSCI.2126-10.2010.
104. Keimpema E., Tortoriello G., Alpár A., Capsoni S., Arisi I., Calvigioni D., Hu S.S.-J., Cattaneo A., Doherty P., Mackie K., Harkany T. Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:1935-1940. 10.1073/pnas.1212563110.
105. Kim D., Thayer S.A. Cannabinoids inhibit the formation of new synapses between hippocampal neurons in culture. J. Neurosci. 2001, 21:RC146.
106. Korb E., Finkbeiner S. Arc in synaptic plasticity: from gene to behavior. Trends Neurosci. 2011, 34:591-598. 10.1016/j.tins.2011.08.007.
107. Korem N., Akirav I. Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing. Neuropsychopharmacology 2014, 39:2709-2722. 10.1038/npp.2014.132.
108. Kosten T.A., Ambrosio E. HPA axis function and drug addictive behaviors: insights from studies with Lewis and Fischer 344 inbred rats. Psychoneuroendocrinology 2002, 27:35-69.
109. Kowalczyk T., Pontious A., Englund C., Daza R.A.M., Bedogni F., Hodge R., Attardo A., Bell C., Huttner W.B., Hevner R.F. Intermediate neuronal progenitors (basal progenitors) produce pyramidal-projection neurons for all layers of cerebral cortex. Cereb. Cortex 2009, 19:2439-2450. 10.1093/cercor/bhn260.
110. Lee T.T.-Y., Hill M.N., Hillard C.J., Gorzalka B.B. Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. Synapse 2013, 67:4-10. 10.1002/syn.21609.
111. Lee T.T.Y., Wainwright S.R., Hill M.N., Galea L.A.M., Gorzalka B.B. Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization. Hippocampus 2014, 24:280-292. 10.1002/hipo.22221.
112. Lenroot R.K., Giedd J.N. Sex differences in the adolescent brain. Brain Cogn. 2010, 72:46-55. 10.1016/j.bandc.2009.10.008.
113. Lenroot R.K., Giedd J.N. Brain development in children and adolescents: insights from anatomical magnetic resonance imaging. Neurosci. Biobehav. Rev. 2006, 30:718-729. 10.1016/j.neubiorev.2006.06.001.
114. Lenroot R.K., Gogtay N., Greenstein D.K., Wells E.M., Wallace G.L., Clasen L.S., Blumenthal J.D., Lerch J., Zijdenbos A.P., Evans A.C., Thompson P.M., Giedd J.N. Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage 2007, 36:1065-1073. 10.1016/j.neuroimage.2007.03.053.
115. Llorente-Berzal A., Puighermanal E., Burokas A., Ozaita A., Maldonado R., Marco E.M., Viveros M.-P. Sex-dependent psychoneuroendocrine effects of THC and MDMA in an animal model of adolescent drug consumption. PLOS ONE 2013, 8:e78386. 10.1371/journal.pone.0078386.
116. Long L.E., Lind J., Webster M., Weickert C.S. Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. BMC Neurosci. 2012, 13:87. 10.1186/1471-2202-13-87.
117. Lopez-Fernandez M.A., Montaron M.F., Varea E., Rougon G., Venero C., Abrous D.N., Sandi C. Upregulation of polysialylated neural cell adhesion molecule in the dorsal hippocampus after contextual fear conditioning is involved in long-term memory formation. J. Neurosci. 2007, 27:4552-4561. 10.1523/JNEUROSCI.0396-07.2007.
118. López-Gallardo M., López-Rodríguez A.B., Llorente-Berzal Á., Rotllant D., Mackie K., Armario A., Nadal R., Viveros M.-P.P., Lopez-Gallardo M., Lopez-Rodriguez A.B., Llorente-Berzal A. Maternal deprivation and adolescent cannabinoid exposure impact hippocampal astrocytes, CB1 receptors and brain-derived neurotrophic factor in a sexually dimorphic fashion. Neuroscience 2012, 204:90-103. S0306-4522(11)01149-3 [pii]. 10.1016/j.neuroscience.2011.09.063.
119. Lopez-Rodriguez A.B., Llorente-Berzal A., Garcia-Segura L.M., Viveros M.-P. Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats. Br. J. Pharmacol. 2014, 171:1435-1447. 10.1111/bph.12519.
120. Lozano J., Garcia-Algar O., Marchei E., Vall O., Monleon T., Giovannandrea R.D., Pichini S. Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr. 2007, 96:1734-1737. 10.1111/j.1651-2227.2007.00535.x.
121. Maccarrone M., Guzmán M., Mackie K., Doherty P., Harkany T. Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. Nat. Rev. Neurosci. 2014, 15:786-801. 10.1038/nrn3846.
122. Maj P.F., Collu M., Fadda P., Cattaneo A., Racagni G., Riva M.A. Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone. Eur. J. Neurosci. 2007, 25:3305-3311. 10.1111/j.1460-9568.2007.05565.x.
123. Marco E.M., Granstrem O., Moreno E., Llorente R., Adriani W., Laviola G., Viveros M.P. Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats. Eur. J. Pharmacol. 2007, 557:37-43. S0014-2999(06)01268-4 [pii]. 10.1016/j.ejphar.2006.11.013.
124. Marco E.M., Llorente R., López-Gallardo M., Mela V., Llorente-Berzal Á., Prada C., Viveros M.-P. The maternal deprivation animal model revisited. Neurosci. Biobehav. Rev. 2015, 51:151-163. 10.1016/j.neubiorev.2015.01.015.
125. Marco E.M., Rubino T., Adriani W., Viveros M.P., Parolaro D., Laviola G. Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. Brain Res. 2009, 1257:25-31. 10.1016/j.brainres.2008.12.037.
126. Mateos B., Borcel E., Loriga R., Luesu W., Bini V., Llorente R., Castelli M.P., Viveros M.P. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors. J. Psychopharmacol. 2011, 25:1676-1690. 10.1177/0269881110370503.
127. Mato S., Del Olmo E., Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur. J. Neurosci. 2003, 17:1747-1754.
128. McLaughlin C.R., Martin B.R., Compton D.R., Abood M.E. Cannabinoid receptors in developing rats: detection of mRNA and receptor binding. Drug Alcohol Depend. 1994, 36:27-31.
129. McPartland J.M., Glass M., Pertwee R.G. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br. J. Pharmacol. 2007, 152:583-593. 10.1038/sj.bjp.0707399.
130. McQueeny T., Padula C.B., Price J., Medina K.L., Logan P., Tapert S.F. Gender effects on amygdala morphometry in adolescent marijuana users. Behav. Brain Res. 2011, 224:128-134. S0166-4328(11)00436-0 [pii]. 10.1016/j.bbr.2011.05.031.
131. Meier M.H., Caspi A., Ambler A., Harrington H., Houts R., Keefe R.S.E., McDonald K., Ward A., Poulton R., Moffitt T.E. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E2657-E2664. 10.1073/pnas.1206820109.
132. Mereu G., Fa M., Ferraro L., Cagiano R., Antonelli T., Tattoli M., Ghiglieri V., Tanganelli S., Gessa G.L., Cuomo V. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4915-4920. 10.1073/pnas.0537849100.
133. Mitsuhiro S.S., Chalem E., Barros M.C., Guinsburg R., Laranjeira R. Prevalence of cocaine and marijuana use in the last trimester of adolescent pregnancy: socio-demographic, psychosocial and behavioral characteristics. Addict. Behav. 2007, 32:392-397. S0306-4603(06)00151-1 [pii]. 10.1016/j.addbeh.2006.05.001.
134. Molina-Holgado F., Amaro A., Gonzalez M.I., Alvarez F.J., Leret M.L. Effect of maternal delta 9-tetrahydrocannabinol on developing serotonergic system. Eur. J. Pharmacol. 1996, 316:39-42.
135. Molina-Holgado F., Molina-Holgado E., Leret M.L., González M.I., Reader T.A. Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments. Neurochem. Res. 1993, 18:1183-1191.
136. Moore D.G., Turner J.D., Parrott A.C., Goodwin J.E., Fulton S.E., Min M.O., Fox H.C., Braddick F.M., Axelsson E.L., Lynch S., Ribeiro H., Frostick C.J., Singer L.T. During pregnancy, recreational drug-using women stop taking ecstasy (3,4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: initial findings from the Development and Infancy Study. J. Psychopharmacol. 2010, 24:1403-1410. 10.1177/0269881109348165.
137. Moore H., Jentsch J.D., Ghajarnia M., Geyer M.A., Grace A.A. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol. Psychiatry 2006, 60:253-264. 10.1016/j.biopsych.2006.01.003.
138. Morel L.J., Giros B., Dauge V. Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats. Neuropsychopharmacology 2009, 34:2469-2476. 10.1038/npp.2009.70.
139. Moreno M., Trigo J.M., Escuredo L., Rodriguez de Fonseca F., Navarro M. Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats. Pharmacol. Biochem. Behav. 2003, 75:565-575. S0091305703001175 [pii].
140. Morishita J., Okamoto Y., Tsuboi K., Ueno M., Sakamoto H., Maekawa N., Ueda N. Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain. J. Neurochem. 2005, 94:753-762. 10.1111/j.1471-4159.2005.03234.x.
141. Morris C.V., DiNieri J.A., Szutorisz H., Hurd Y.L. Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment. Eur. J. Neurosci. 2011, 34:1574-1583. 10.1111/j.1460-9568.2011.07884.x.
142. Mulder J., Aguado T., Keimpema E., Barabas K., Ballester Rosado C.J., Nguyen L., Monory K., Marsicano G., Di Marzo V., Hurd Y.L., Guillemot F., Mackie K., Lutz B., Guzman M., Lu H.C., Galve-Roperh I., Harkany T. Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:8760-8765. 10.1073/pnas.0803545105.
143. Nacher J., Guirado R., Castillo-Gómez E. Structural plasticity of interneurons in the adult brain: role of PSA-NCAM and implications for psychiatric disorders. Neurochem. Res. 2013, 38:1122-1133. 10.1007/s11064-013-0977-4.
144. Newsom R.J., Kelly S.J. Perinatal delta-9-tetrahydrocannabinol exposure disrupts social and open field behavior in adult male rats. Neurotoxicol. Teratol. 2008, 30:213-219. S0892-0362(07)00367-4 [pii]. 10.1016/j.ntt.2007.12.007.
145. Noland J.S., Singer L.T., Short E.J., Minnes S., Arendt R.E., Kirchner H.L., Bearer C. Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol. Teratol. 2005, 27:429-438. S0892-0362(05)00040-1 [pii]. 10.1016/j.ntt.2005.02.001.
146. O'Shea M., McGregor I.S., Mallet P.E. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J. Psychopharmacol. 2006, 20:611-621.
147. O'Shea M., Singh M.E., McGregor I.S., Mallet P.E. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J. Psychopharmacol. 2004, 18:502-508.
148. O'Tuathaigh C.M.P., Hryniewiecka M., Behan A., Tighe O., Coughlan C., Desbonnet L., Cannon M., Karayiorgou M., Gogos J.A., Cotter D.R., Waddington J.L. Chronic adolescent exposure to δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes. Neuropsychopharmacology 2010, 35:2262-2273. 10.1038/npp.2010.100.
149. Oudin M.J., Gajendra S., Williams G., Hobbs C., Lalli G., Doherty P. Endocannabinoids regulate the migration of subventricular zone-derived neuroblasts in the postnatal brain. J. Neurosci. 2011, 31:4000-4011. 10.1523/jneurosci.5483-10.2011.
150. Padula C.B., Schweinsburg A.D., Tapert S.F. Spatial working memory performance and fMRI activation interaction in abstinent adolescent marijuana users. Psychol. Addict. Behav. 2007, 21:478-487. 10.1037/0893-164X.21.4.478.
151. Paria B.C., Dey S.K. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem. Phys. Lipids 2000, 108:211-220. S0009308400001973 [pii].
152. Perez-Rosado A., Gomez M., Manzanares J., Ramos J.A., Fernandez-Ruiz J. Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Delta(9)-tetrahydrocannabinol. Neurotoxicol. Res. 2002, 4:211-218. 10.1080/10298420290023936.
153. Perez-Rosado A., Manzanares J., Fernandez-Ruiz J., Ramos J.A. Prenatal Delta(9)-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences. Brain Res. Dev. Brain Res. 2000, 120:77-81.
154. Pertwee R.G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br. J. Pharmacol. 2008, 153:199-215. 10.1038/sj.bjp.0707442.
155. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl). 2005, 177:245-255. 10.1007/s00213-004-2048-7.
156. Pistis M., Perra S., Pillolla G., Melis M., Muntoni A.L., Gessa G.L. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol. Psychiatry 2004, 56:86-94.
157. Pope H.G., Gruber A.J., Hudson J.I., Huestis M.A., Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch. Gen. Psychiatry 2001, 58:909-915. yoa20391 [pii].
158. Quinn H.R., Matsumoto I., Callaghan P.D., Long L.E., Arnold J.C., Gunasekaran N., Thompson M.R., Dawson B., Mallet P.E., Kashem M.A., Matsuda-Matsumoto H., Iwazaki T., McGregor I.S. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology 2008, 33:1113-1126.
159. Raver S.M., Keller A. Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms. Neuropharmacology 2014, 86:161-173. 10.1016/j.neuropharm.2014.07.006.
160. Raznahan A., Shaw P.W., Lerch J.P., Clasen L.S., Greenstein D., Berman R., Pipitone J., Chakravarty M.M., Giedd J.N. Longitudinal four-dimensional mapping of subcortical anatomy in human development. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:1592-1597. 10.1073/pnas.1316911111.
161. Realini N., Rubino T., Parolaro D. Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. Pharmacol. Res. 2009, 60:132-138.
162. Realini N., Vigano D., Guidali C., Zamberletti E., Rubino T., Parolaro D. Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. Neuropharmacology 2011, 60:235-243. S0028-3908(10)00224-8 [pii]. 10.1016/j.neuropharm.2010.09.003.
163. Reimold M., Batra A., Knobel A., Smolka M.N., Zimmer A., Mann K., Solbach C., Reischl G., Schwärzler F., Gründer G., Machulla H.-J., Bares R., Heinz A. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Mol. Psychiatry 2008, 13:606-613. 557. 10.1038/sj.mp.4002149.
164. Renard J., Krebs M., Le Pen G., Jay T.M. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Front. Neurosci. 2014, 8:1-14. 10.3389/fnins.2014.00361.
165. Renard J., Krebs M.O., Jay T.M., Le Pen G. Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology (Berl). 2013, 225:781-790. 10.1007/s00213-012-2865-z.
166. Rivkin M.J., Davis P.E., Lemaster J.L., Cabral H.J., Warfield S.K., Mulkern R.V., Robson C.D., Rose-Jacobs R., Frank D.A. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana. Pediatrics 2008, 121:741-750. 10.1542/peds.2007-1399.
167. Robbins T.W. Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos. Trans. R. Soc. Lond. Ser. B: Biol. Sci. 2007, 362:917-932. H01V0404612T2871 [pii]. 10.1098/rstb.2007.2097.
168. Rodriguez de Fonseca F., Ramos J.A., Bonnin A., Fernandez-Ruiz J.J. Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport 1993, 4:135-138.
169. Romero J., Garcia-Palomero E., Berrendero F., Garcia-Gil L., Hernandez M.L., Ramos J.A., Fernandez-Ruiz J.J. Atypical location of cannabinoid receptors in white matter areas during rat brain development. Synapse 1997, 26:317-323.
170. Ronn L.C., Berezin V., Bock E. The neural cell adhesion molecule in synaptic plasticity and ageing. Int. J. Dev. Neurosci. 2000, 18:193-199.
171. Rubino T., Parolaro D. Long lasting consequences of cannabis exposure in adolescence. Mol. Cell. Endocrinol. 2008, 286:S108-S113.
172. Rubino T., Prini P., Piscitelli F., Zamberletti E., Trusel M., Melis M., Sagheddu C., Ligresti A., Tonini R., Di Marzo V., Parolaro D. Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex. Neurobiol. Dis. 2014, (in press). 10.1016/j.nbd.2014.09.015.
173. Rubino T., Realini N., Braida D., Guidi S., Capurro V., Vigano D., Guidali C., Pinter M., Sala M., Bartesaghi R., Parolaro D. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus 2009, 19:763-772.
174. Rubino T., Vigano' D., Realini N., Guidali C., Braida D., Capurro V., Castiglioni C., Cherubino F., Romualdi P., Candeletti S., Sala M., Parolaro D., Vigano D. Chronic Delta(9)-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 2008, 33:2760-2771. 10.1038/sj.npp.1301664.
175. Rubio P., Rodriguez de Fonseca F., Munoz R.M., Ariznavarreta C., Martin-Calderon J.L., Navarro M. Long-term behavioral effects of perinatal exposure to delta 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis. Life Sci. 1995, 56:2169-2176.
176. Saez T.M.M., Aronne M.P., Caltana L., Brusco A.H. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex. J. Neurochem. 2014, 129:637-648. 10.1111/jnc.12636.
177. Saurel-Cubizolles M.-J., Prunet C., Blondel B. Cannabis use during pregnancy in France in 2010. BJOG 2014, 121:971-977. 10.1111/1471-0528.12626.
178. Schneider M. Cannabis use in pregnancy and early life and its consequences: animal models. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259:383-393. 10.1007/s00406-009-0026-0.
179. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict. Biol. 2008, 13:253-263.
180. Schneider M., Drews E., Koch M. Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2. Behav. Pharmacol. 2005, 16:447-454.
181. Schneider M., Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 2003, 28:1760-1769.
182. Schulz S., Becker T., Nagel U., von Ameln-Mayerhofer A., Koch M. Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making. Pharmacol. Biochem. Behav. 2013, 106:91-100. S0091-3057(13)00077-4 [pii]. 10.1016/j.pbb.2013.03.011.
183. Schweinsburg A.D., Schweinsburg B.C., Medina K.L., McQueeny T., Brown S.A., Tapert S.F. The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J. Psychoactive Drugs 2010, 42:401-412.
184. Segev A., Rubin A.S., Abush H., Richter-Levin G., Akirav I. Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression. Neuropsychopharmacology 2014, 39:919-933. 10.1038/npp.2013.292.
185. Shabani M., Hosseinmardi N., Haghani M., Shaibani V., Janahmadi M. Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring. Neuroscience 2011, 172:139-152. S0306-4522(10)01361-8 [pii]. 10.1016/j.neuroscience.2010.10.031.
186. Shabani M., Mahnam A., Sheibani V., Janahmadi M. Alterations in the intrinsic burst activity of Purkinje neurons in offspring maternally exposed to the CB1 cannabinoid agonist WIN 55212-2. J. Membr. Biol. 2014, 247:63-72. 10.1007/s00232-013-9612-1.
187. Silva L., Zhao N., Popp S., Dow-Edwards D. Prenatal tetrahydrocannabinol (THC) alters cognitive function and amphetamine response from weaning to adulthood in the rat. Neurotoxicol. Teratol. 2012, 34:63-71. S0892-0362(11)00205-4 [pii]. 10.1016/j.ntt.2011.10.006.
188. Smith A.M., Fried P.A., Hogan M.J., Cameron I. Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol. Teratol. 2006, 28:286-295. S0892-0362(05)00180-7 [pii]. 10.1016/j.ntt.2005.12.008.
189. Smith A.M., Fried P.A., Hogan M.J., Cameron I. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol. Teratol. 2004, 26:533-542. S0892036204000662 [pii]. 10.1016/j.ntt.2004.04.004.
190. Smith M.J., Cobia D.J., Reilly J.L., Gilman J.M., Roberts A.G., Alpert K.I., Wang L., Breiter H.C., Csernansky J.G. Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects. Hippocampus 2015, 10.1002/hipo.22427.
191. Spano M.S., Ellgren M., Wang X., Hurd Y.L. Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol. Psychiatry 2007, 61:554-563. S0006-3223(06)00557-9 [pii]. 10.1016/j.biopsych.2006.03.073.
192. Stopponi S., Soverchia L., Ubaldi M., Cippitelli A., Serpelloni G., Ciccocioppo R. Chronic THC during adolescence increases the vulnerability to stress-induced relapse to heroin seeking in adult rats. Eur. Neuropsychopharmacol. 2014, 24:1037-1045. 10.1016/j.euroneuro.2013.12.012.
193. Suarez I., Bodega G., Fernandez-Ruiz J., Ramos J.A., Rubio M., Fernandez B. Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure. Cerebellum 2004, 3:66-74.
194. Suarez I., Bodega G., Fernandez-Ruiz J.J., Ramos J.A., Rubio M., Fernandez B. Reduced glial fibrillary acidic protein and glutamine synthetase expression in astrocytes and Bergmann glial cells in the rat cerebellum caused by delta(9)-tetrahydrocannabinol administration during development. Dev. Neurosci. 2002, 24:300-312.
195. Suarez I., Bodega G., Rubio M., Fernandez-Ruiz J.J., Ramos J.A., Fernandez B. Prenatal cannabinoid exposure down-regulates glutamate transporter expressions (GLAST and EAAC1) in the rat cerebellum. Dev. Neurosci. 2004, 26:45-53.
196. Suarez J., Llorente R., Romero-Zerbo S.Y., Mateos B., Bermudez-Silva F.J., de Fonseca F.R., Viveros M.P. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus 2009, 19:623-632. 10.1002/hipo.20537.
197. Substance Abuse and Mental Health Services Administration Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings 2014.
198. Substance Abuse and Mental Health Services Administration Behavioral Health Barometer 2014.
199. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health 2013.
200. Substance Abuse and Mental Health Services Administration Substance Use among Women During Pregnancy and Following Childbirth, The NSDUH Report 2009.
201. Sun X., Dey S.K. Aspects of endocannabinoid signaling in periimplantation biology. Mol. Cell. Endocrinol. 2008, 286:S3-S11. S0303-7207(08)00008-7 [pii]. 10.1016/j.mce.2008.01.002.
202. Szutorisz H., DiNieri J.a, Sweet E., Egervari G., Michaelides M., Carter J.M., Ren Y., Miller M.L., Blitzer R.D., Hurd Y.L. Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology 2014, 39:1315-1323. 10.1038/npp.2013.352.
203. Tantra M., Kröcher T., Papiol S., Winkler D., Röckle I., Jatho J., Burkhardt H., Ronnenberg A., Gerardy-Schahn R., Ehrenreich H., Hildebrandt H. St8sia2 deficiency plus juvenile cannabis exposure in mice synergistically affect higher cognition in adulthood. Behav. Brain Res. 2014, 10.1016/j.bbr.2014.08.062.
204. Tapert S.F., Schweinsburg A.D., Drummond S.P.A., Paulus M.P., Brown S.A., Yang T.T., Frank L.R. Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berl). 2007, 194:173-183. 10.1007/s00213-007-0823-y.
205. Thanos P.K., Michaelides M., Umegaki H., Volkow N.D. D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse 2008, 62:481-486. 10.1002/syn.20523.
206. Tomasiewicz H.C., Jacobs M.M., Wilkinson M.B., Wilson S.P., Nestler E.J., Hurd Y.L. Proenkephalin mediates the enduring effects of adolescent cannabis exposure associated with adult opiate vulnerability. Biol. Psychiatry 2012, 72:803-810. S0006-3223(12)00409-X [pii]. 10.1016/j.biopsych.2012.04.026.
207. Tortoriello G., Morris C.V., Alpar A., Fuzik J., Shirran S.L., Calvigioni D., Keimpema E., Botting C.H., Reinecke K., Herdegen T., Courtney M., Hurd Y.L., Harkany T. Miswiring the brain: δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J. 2014, 33:668-685. 10.1002/embj.201386035.
208. Tree K.C., Scotto di Perretolo M., Peyronnet J., Cayetanot F. In utero cannabinoid exposure alters breathing and the response to hypoxia in newborn mice. Eur. J. Neurosci. 2014, 40:2196-2204. 10.1111/ejn.12588.
209. Trezza V., Campolongo P., Cassano T., Macheda T., Dipasquale P., Carratu M.R., Gaetani S., Cuomo V. Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats. Psychopharmacology (Berl). 2008, 198:529-537. 10.1007/s00213-008-1162-3.
210. Trezza V., Campolongo P., Manduca A., Morena M., Palmery M., Vanderschuren L.J., Cuomo V. Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance. Front. Behav. Neurosci. 2012, 6:2. 10.3389/fnbeh.2012.00002.
211. U.S.Department of Health and Human Services Blending perspective and building common ground. A report to Congress on substance abuse and child protection 1999, [WWW Document]. URL: http://aspe.hhs.gov/hsp/subabuse99/subabuse.htm (accessed 10.06.14).
212. United Nations Office on Drugs and Crime World Drug Report 2013. Malta 2013.
213. Van Zundert B., Yoshii A., Constantine-Paton M. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal. Trends Neurosci. 2004, 27:428-437. S0166-2236(04)00164-X [pii]. 10.1016/j.tins.2004.05.010.
214. Vassoler F.M., Johnson N.L., Byrnes E.M. Female adolescent exposure to cannabinoids causes transgenerational effects on morphine sensitization in female offspring in the absence of in utero exposure. J. Psychopharmacol. 2013, 27:1015-1022. 10.1177/0269881113503504.
215. Vela G., Fuentes J.A., Bonnin A., Fernandez-Ruiz J., Ruiz-Gayo M. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res. 1995, 680:142-147.
216. Vela G., Martin S., Garcia-Gil L., Crespo J.A., Ruiz-Gayo M., Javier Fernandez-Ruiz J., Garcia-Lecumberri C., Pelaprat D., Fuentes J.A., Ramos J.A., Ambrosio E. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats. Brain Res. 1998, 807:101-109. S0006-8993(98)00766-5 [pii].
217. Venero C., Herrero A.I., Touyarot K., Cambon K., Lopez-Fernandez M.A., Berezin V., Bock E., Sandi C. Hippocampal up-regulation of NCAM expression and polysialylation plays a key role on spatial memory. Eur. J. Neurosci. 2006, 23:1585-1595.
218. Viveros M.P., Llorente R., Suarez J., Llorente-Berzal A., Lopez-Gallardo M., de Fonseca F.R., Rodriguez de Fonseca F. The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications. J. Psychopharmacol. 2011, 26:164-176. 10.1177/0269881111408956.
219. Viveros M.P., Marco E.M., Lopez-Gallardo M., Garcia-Segura L.M., Wagner E.J. Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. Neurosci. Biobehav. Rev. 2011, 35:1740-1751. S0149-7634(10)00145-4 [pii]. 10.1016/j.neubiorev.2010.09.005.
220. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M. Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Mol. Psychiatry 2004, 9:557-569. 10.1038/sj.mp.4001507 4001507.
221. Walters D.E., Carr L.A. Perinatal exposure to cannabinoids alters neurochemical development in rat brain. Pharmacol. Biochem. Behav. 1988, 29:213-216. S0091-3057(88)90300-0 [pii].
222. Wang X., Dow-Edwards D., Anderson V., Minkoff H., Hurd Y.L. Discrete opioid gene expression impairment in the human fetal brain associated with maternal marijuana use. Pharmacogenomics J. 2006, 6:255-264. 10.1038/sj.tpj.6500375.
223. Wang X., Dow-Edwards D., Anderson V., Minkoff H., Hurd Y.L. In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus. Biol. Psychiatry 2004, 56:909-915. S0006-3223(04)01095-9 [pii]. 10.1016/j.biopsych.2004.10.015.
224. Wang X., Dow-Edwards D., Keller E., Hurd Y.L. Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain. Neuroscience 2003, 118:681-694. S0306452203000204 [pii].
225. Warner T.D., Behnke M., Eyler F.D., Padgett K., Leonard C., Hou W., Garvan C.W., Schmalfuss I.M., Blackband S.J. Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children. Pediatrics 2006, 118:2014-2024. 10.1542/peds.2006-0003.
226. Wegener N., Koch M. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment. Brain Res. 2009, 1253:81-91. S0006-8993(08)02848-5 [pii]. 10.1016/j.brainres.2008.11.081.
227. Wenger T., Gerendai I., Fezza F., Gonzalez S., Bisogno T., Fernandez-Ruiz J., Di Marzo V. The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. Life Sci. 2002, 70:1407-1414.
228. Wu C.S., Jew C.P., Lu H.C. Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain. Futur. Neurol. 2011, 6:459-480.
229. Wu C.-S., Morgan D., Jew C.P., Andrews M.-J., Leishman E., Spencer C.M., Czyzyk T., Bradshaw H., Mackie K., Lu H.-C. Long-term consequences of perinatal fatty acid amino hydrolase inhibition. Br. J. Pharmacol. 2014, 171:1420-1434.
230. Wu C.S., Zhu J., Wager-Miller J., Wang S., O'Leary D., Monory K., Lutz B., Mackie K., Lu H.C. Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur. J. Neurosci. 2010, 32:693-706. 10.1111/j.1460-9568.2010.07337.x.
231. Yamamoto K., Shinba T., Yoshii M. Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view. Psychiatry Clin. Neurosci. 2014, 68:1-20. 10.1111/pcn.12126.
232. Yan H.C., Cao X., Das M., Zhu X.H., Gao T.M. Behavioral animal models of depression. Neurosci. Bull. 2010, 26:327-337. 10.1007/s12264-010-0323-7.
233. Zamberletti E., Beggiato S., Steardo L., Prini P., Antonelli T., Ferraro L., Rubino T., Parolaro D. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats. Neurobiol. Dis. 2014, 63:35-47. 10.1016/j.nbd.2013.10.028.
234. Zamberletti E., Prini P., Speziali S., Gabaglio M., Solinas M., Parolaro D., Rubino T. Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. Neuroscience 2012, 204:245-257. S0306-4522(11)01323-6 [pii]. 10.1016/j.neuroscience.2011.11.038.
235. Zhang Y., Landthaler M., Schlussman S.D., Yuferov V., Ho A., Tuschl T., Kreek M.J. Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin. Neuroscience 2009, 158:474-483. 10.1016/j.neuroscience.2008.09.039.
236. Zhu P.J., Lovinger D.M. Developmental alteration of endocannabinoid retrograde signaling in the hippocampus. J. Neurophysiol. 2010, 103:1123-1129. 10.1152/jn.00327.2009.
237. Zurolo E., Iyer A.M., Spliet W.G., Van Rijen P.C., Troost D., Gorter J.A., Aronica E. CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies. Neuroscience 2010, 170:28-41. S0306-4522(10)00958-9 [pii]. 10.1016/j.neuroscience.2010.07.004.